Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lehmann

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Current Opinion in Drug Discovery & Development|June 27, 2003
Orphan nuclear receptors: from new ligand discovery technologies to novel signaling pathwaysA K Shiau, P Coward, M Schwarz, et al.
The Israel Medical Association Journal : IMAJ|April 17, 2001
Arterial thromboembolism from a distal aortic thrombus in a patient with Crohn's diseaseJ M Lehmann, A Shnaker, D Silverberg, et al.
Recent Progress in Hormone Research|November 5, 1999
The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathwaysS A Kliewer, J M Lehmann, M V Milburn, et al.
Onkologie|December 1, 1989
[Step-wise expression of melanoma-associated antigens in tumor progression]J M Lehmann, B Holzmann, U Rothbächer, et al.
Cancer Research|September 15, 1991
Identification of retinoids with nuclear receptor subtype-selective activitiesJ M Lehmann, M I Dawson, P D Hobbs, et al.
Molecular and Cellular Biology|October 1, 1992
COUP orphan receptors are negative regulators of retinoic acid response pathwaysP Tran, X K Zhang, G Salbert, et al.
The Journal of Biological Chemistry|February 7, 1997
Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugsJ M Lehmann, J M Lenhard, B B Oliver, et al.
Harefuah|March 25, 2008
[Stents in dialysis vascular access--do they promise improved high quality prolonged access use]Osnat Klein, Eleonora Plotkin, Igal Gritun, et al.
Invasion & Metastasis|January 1, 1989
Functional aspects of three molecules associated with metastasis development in human malignant melanomaJ P Johnson, J M Lehmann, B G Stade, et al.
Cancer Research|February 1, 1987
Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000J M Lehmann, B Holzmann, E W Breitbart, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Current Opinion in Drug Discovery & Development|June 27, 2003
Orphan nuclear receptors: from new ligand discovery technologies to novel signaling pathwaysA K Shiau, P Coward, M Schwarz, et al.
The Israel Medical Association Journal : IMAJ|April 17, 2001
Arterial thromboembolism from a distal aortic thrombus in a patient with Crohn's diseaseJ M Lehmann, A Shnaker, D Silverberg, et al.
Recent Progress in Hormone Research|November 5, 1999
The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathwaysS A Kliewer, J M Lehmann, M V Milburn, et al.
Onkologie|December 1, 1989
[Step-wise expression of melanoma-associated antigens in tumor progression]J M Lehmann, B Holzmann, U Rothbächer, et al.
Cancer Research|September 15, 1991
Identification of retinoids with nuclear receptor subtype-selective activitiesJ M Lehmann, M I Dawson, P D Hobbs, et al.
Molecular and Cellular Biology|October 1, 1992
COUP orphan receptors are negative regulators of retinoic acid response pathwaysP Tran, X K Zhang, G Salbert, et al.
The Journal of Biological Chemistry|February 7, 1997
Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugsJ M Lehmann, J M Lenhard, B B Oliver, et al.
Harefuah|March 25, 2008
[Stents in dialysis vascular access--do they promise improved high quality prolonged access use]Osnat Klein, Eleonora Plotkin, Igal Gritun, et al.
Invasion & Metastasis|January 1, 1989
Functional aspects of three molecules associated with metastasis development in human malignant melanomaJ P Johnson, J M Lehmann, B G Stade, et al.
Cancer Research|February 1, 1987
Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000J M Lehmann, B Holzmann, E W Breitbart, et al.
Pageof 6